413. Deputy Eamon Gilmore asked the Minister for Health if the drug, Nadolol, has been removed from the drug payment scheme; and if he will make a statement on the matter. [10288/15]

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013, therefore, the matter has been referred to the HSE for attention and direct reply to you. If you have not received a reply from the HSE within 15 working days please contact my Private Office and they will follow up the matter with them.